Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
Hurteloup
P
P
Chollet
P
P
Roche
H
H
Chevallier
B
B
Cappelaere
P
P
Van Glabbece
M
M
Hayat
M
M
Armand
J P
JP
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin; C030851:esorubicin